ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,285,620 shares; 2025Q1: 4,148,428 shares; 2025Q2: 4,148,428 shares; 2025Q3: 4,148,428 shares; 2025Q4: 4,148,428 shares; 2026Q1: 4,148,428 shares; 2026Q2: 4,148,428 shares; 2026Q3: 4,148,428 shares 4,148,428 $346M 16.79% 0 Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 16,216,216 shares; 2025Q1: 16,216,216 shares; 2025Q2: 17,857,083 shares; 2025Q3: 17,857,083 shares; 2025Q4: 17,857,083 shares; 2026Q1: 16,382,812 shares; 2026Q2: 17,891,812 shares; 2026Q3: 20,089,932 shares 20,089,932 $295M 14.31% +2,198,120 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,685,448 shares; 2025Q1: 2,685,448 shares; 2025Q2: 2,685,448 shares; 2025Q3: 2,685,448 shares; 2025Q4: 3,685,448 shares; 2026Q1: 3,685,448 shares; 2026Q2: 2,985,448 shares; 2026Q3: 2,485,448 shares 2,485,448 $221M 10.75% -500,000 Timeline KRSA KORSANA BIOSCIENCES INC More: the full row for KORSANA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,549,585 shares 4,549,585 $146M 7.07% new Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 3,257,639 shares; 2025Q2: 8,884,263 shares; 2025Q3: 12,681,043 shares; 2025Q4: 13,740,375 shares; 2026Q1: 13,740,375 shares; 2026Q2: 14,745,943 shares; 2026Q3: 19,568,534 shares 19,568,534 $101M 4.91% +4,822,591 Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,762,462 shares; 2025Q1: 12,762,462 shares; 2025Q2: 12,762,462 shares; 2025Q3: 13,161,462 shares; 2025Q4: 7,315,547 shares; 2026Q1: 10,346,926 shares; 2026Q2: 10,346,926 shares; 2026Q3: 10,346,926 shares 10,346,926 $79.4M 3.86% 0 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 3,603,595 shares 3,603,595 $76.7M 3.73% new Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,744,373 shares; 2025Q1: 1,744,373 shares; 2025Q2: 1,000,000 shares; 2025Q3: 960,803 shares; 2025Q4: 1,000,000 shares; 2026Q1: 1,180,000 shares; 2026Q2: 1,180,000 shares; 2026Q3: 822,020 shares 822,020 $72.4M 3.52% -357,980 Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,882,709 shares; 2025Q1: 3,882,709 shares; 2025Q2: 3,882,709 shares; 2025Q3: 3,882,709 shares; 2025Q4: 3,882,709 shares; 2026Q1: 3,882,709 shares; 2026Q2: 3,257,917 shares; 2026Q3: 3,257,917 shares 3,257,917 $67.1M 3.26% 0 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 499,966 shares; 2025Q4: 1,943,766 shares; 2026Q1: 3,041,719 shares; 2026Q2: 3,041,719 shares; 2026Q3: 3,041,719 shares 3,041,719 $58M 2.82% 0 Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,684,411 shares; 2025Q1: 5,684,411 shares; 2025Q2: 4,755,411 shares; 2025Q3: 4,000,000 shares; 2025Q4: 2,000,000 shares; 2026Q1: 2,000,000 shares; 2026Q2: 1,642,166 shares; 2026Q3: 1,642,166 shares 1,642,166 $52.6M 2.55% 0 Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,212,731 shares; 2026Q2: 3,212,731 shares; 2026Q3: 3,212,731 shares 3,212,731 $51.4M 2.5% 0 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,220,364 shares; 2025Q3: 3,220,364 shares; 2025Q4: 3,220,364 shares; 2026Q1: 3,220,364 shares; 2026Q2: 3,220,364 shares; 2026Q3: 3,220,364 shares 3,220,364 $45.2M 2.2% 0 Timeline ACHV ACHIEVE LIFE SCIENCE INC More: the full row for ACHIEVE LIFE SCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,751,032 shares; 2026Q3: 5,502,064 shares 5,502,064 $44.5M 2.16% +2,751,032 Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,230,769 shares; 2025Q4: 1,548,569 shares; 2026Q1: 1,602,034 shares; 2026Q2: 1,602,034 shares; 2026Q3: 1,545,616 shares 1,545,616 $42M 2.04% -56,418 Timeline ORIC ORIC PHARMACEUTICALS INC More: the full row for ORIC PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,394,527 shares; 2025Q1: 3,182,527 shares; 2025Q2: 6,596,885 shares; 2025Q3: 6,596,885 shares; 2025Q4: 5,676,230 shares; 2026Q1: 4,319,765 shares; 2026Q2: 4,319,765 shares; 2026Q3: 2,944,056 shares 2,944,056 $39.7M 1.93% -1,375,709 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,173,913 shares; 2025Q1: 2,173,913 shares; 2025Q2: 2,173,913 shares; 2025Q3: 2,173,913 shares; 2025Q4: 2,173,913 shares; 2026Q1: 2,173,913 shares; 2026Q2: 2,173,913 shares; 2026Q3: 2,173,913 shares 2,173,913 $35M 1.7% 0 Timeline ADRX ADARX PHARMACEUTICALS INC More: the full row for ADARX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,625,793 shares 1,625,793 $32.4M 1.58% new Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,387,864 shares; 2025Q3: 1,387,864 shares; 2025Q4: 2,133,576 shares; 2026Q1: 2,133,576 shares; 2026Q2: 2,133,576 shares; 2026Q3: 2,133,734 shares 2,133,734 $31.1M 1.51% +158 Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,843,380 shares; 2026Q2: 6,844,305 shares; 2026Q3: 7,445,050 shares 7,445,050 $28.1M 1.36% +600,745 Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,023,166 shares; 2025Q1: 5,023,166 shares; 2025Q2: 4,631,216 shares; 2025Q3: 4,631,216 shares; 2025Q4: 5,345,115 shares; 2026Q1: 6,434,990 shares; 2026Q2: 6,434,990 shares; 2026Q3: 6,434,990 shares 6,434,990 $26.8M 1.3% 0 Timeline XFOR X4 PHARMACEUTICALS INC More: the full row for X4 PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 330,525 shares; 2026Q2: 1,934,253 shares; 2026Q3: 7,644,072 shares 7,644,072 $22.2M 1.08% +5,709,819 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,379,965 shares; 2025Q1: 1,379,965 shares; 2025Q2: 1,379,965 shares; 2025Q3: 1,379,965 shares; 2025Q4: 1,379,965 shares; 2026Q1: 1,379,965 shares; 2026Q2: 1,379,965 shares; 2026Q3: 1,379,965 shares 1,379,965 $21.2M 1.03% 0 Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 632,931 shares; 2025Q2: 632,931 shares; 2025Q3: 632,931 shares; 2025Q4: 632,931 shares; 2026Q1: 632,931 shares; 2026Q2: 632,931 shares; 2026Q3: 632,931 shares 632,931 $20.4M 0.99% 0 Timeline PBLS PARABILIS MEDICINES INC More: the full row for PARABILIS MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 625,000 shares; 2026Q3: 625,000 shares 625,000 $20.2M 0.98% 0 Timeline ARVN ARVINAS INC More: the full row for ARVINAS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,952,533 shares 1,952,533 $15.1M 0.73% new Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,957,186 shares; 2025Q1: 2,498,069 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,695,652 shares; 2026Q2: 8,695,652 shares; 2026Q3: 8,695,652 shares 8,695,652 $14.9M 0.72% 0 Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,106,337 shares 5,106,337 $14.9M 0.72% new Timeline ARTV ARTIVA BIOTHERAPEUTICS INC More: the full row for ARTIVA BIOTHERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,609,569 shares; 2025Q1: 1,609,569 shares; 2025Q2: 1,609,569 shares; 2025Q3: 1,609,569 shares; 2025Q4: 1,609,569 shares; 2026Q1: 1,609,569 shares; 2026Q2: 2,043,596 shares; 2026Q3: 2,043,596 shares 2,043,596 $14.6M 0.71% 0 Timeline ANRO ALTO NEUROSCIENCE INC More: the full row for ALTO NEUROSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 500,000 shares; 2026Q2: 500,000 shares; 2026Q3: 500,000 shares 500,000 $12.8M 0.62% 0 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,009,500 shares; 2026Q2: 1,009,500 shares; 2026Q3: 443,431 shares 443,431 $4.39M 0.21% -566,069 Timeline TCGX TCGX ACQUISITION CORP More: the full row for TCGX ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.75M 0.18% new Timeline RACD RESEARCH ALLIANCE CORP IV More: the full row for RESEARCH ALLIANCE CORP IV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.6M 0.17% new Timeline INM INMED PHARMACEUTICALS INC More: the full row for INMED PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 32,685 shares; 2026Q3: 133,378 shares 133,378 $181K 0.01% +100,693 Timeline